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Background. Advances in pain assessment approaches now indicate which measures should be used to capture chronic pain
experiences in children and adolescents. However, there is little guidance on how these tools should best be administered and
reported, such as which time frames to use or how pain scores are categorised as mild, moderate, or severe.Objective. To synthesise
current evidence on unidimensional, single-item pain intensity scale selection, administration, interpretation, and reporting.
Methods.Databases were searched (inception: 18 January 2016) for studies in which unidimensional pain intensity assessments were
used with children and adolescents with chronic pain. Ten quality criteria were developed bymodifying existing recommendations
to evaluate the quality of administration of pain scales most commonly used with children. Results. Forty-six studies met the
inclusion criteria. The highest score achieved was 7 out of a possible 10 (median: 5; IQR: 4–6). Usage of scales varied markedly in
administrator/completer, highest anchors, number of successive assessments, and time referent periods used.Conclusions. Findings
suggest these scales are selected, administered, and interpreted inconsistently, even in studies of the same type. Furthermore,
methods of administration are rarely reported or justified making it impossible to compare findings across studies. This article
concludes by recommending criteria for the future reporting of paediatric chronic pain assessments in studies.
1. Introduction
Chronic pain is frequently defined as pain that persists
beyond the normal tissue healing time, lasting for three or
moremonths [1], and is estimated to affect between 4 and40%
of children [2]. Changes in reported pain guide treatment
decision-making [3] and accurate measurement of pain is
associated with improved outcomes in those with long-
term chronic conditions [4, 5]. A number of publications
recommend that the primary source of information on pain
should be the children themselves in paediatric settings
[6–8]. However, the developmental changes which occur
during childhood and adolescence make the measurement of
paediatric pain particularly challenging [6, 9]. The cognitive
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and metacognitive skills required for a child to give reliable
self-reports of pain (such as the ability to rank-order objects,
consider numerous options simultaneously, and retain and
manipulate information) change significantly during child-
hood and adolescence [10].
Although assessment of pain in children is complex,
there are many single-item pain measures used with this
group [11] and unidimensional pain scales are most often
used to routinely assess paediatric chronic pain [12]. Whilst
they may only provide assessment of one component of
pain, these scales are often combined or included in mul-
tidimensional and composite pain measurement scales [9].
Some of themost commonly used unidimensional pain scales
include visual analogue scales (VASs), numerical rating scales
(NRSs), and faces pain scales (FPSs).
Recent attempts to standardise the assessment of pain
in children and adolescents with chronic pain include the
PedIMMPACT (Paediatric Initiative on Methods, Measure-
ment, and Pain Assessment in Clinical Trials) groups [13]
identification of core outcome domains and measures to
be used in clinical treatment trials. Other moves towards
the standardisation of pain assessment have been made by
PROMIS (Patient-Reported Outcomes Measurement Infor-
mation System) investigators [14] who developed a suite of
patient-reportedmeasures to assess a range of chronic condi-
tions, including pain.Whilst these groups’ recommendations
have been influential in establishing which measures are best
to use with children and adolescents with chronic pain, they
do not provide corresponding recommendations or advice
for how to use and administer pain measures. The lack of
standardisation of the approach to pain assessment suggests
that methods of measurement may be very different between
researchers ostensibly using the same unidimensional pain
intensity scales.
King et al. [2] alerted researchers to the problem that
inconsistent measurement approaches and reporting pose
when establishing the epidemiology of chronic pain in
children and adolescents.Other authors have also highlighted
that significant bias is created through the different measure-
ment approaches used in paediatric pain research [15, 16].
Research attention has not been given to the variation in the
administration of single-item pain assessments or the extent
to which inconsistency in measurement approaches may be a
problem.
Differences in administration are not the only cause for
concern. There is uncertainty about interpretation of pain
assessments, particularly when scores are used to classify
chronic pain in children and adolescents [17]. The three
classifications most commonly used for categorising facets
of pain are mild, moderate, and severe. Systems to aid
categorisation of pain scores into these classifications have
not been well defined in children and few attempts have
been made to standardise classification boundaries. Recently,
attempts to do this in acute emergency care have been
instigated by Tsze et al. [18], who defined ranges of pain scores
associated with mild, moderate, and severe pain categories
(as measured by the FPS-R and the colour analogue scale
(CAS)) in children presenting at emergency departments.
Currently, there is no consensus on the points at which pain
intensity changes classifications from mild to moderate or
from moderate to severe in paediatric chronic pain [17].
To address these issues, a systematic literature review
was undertaken to identify, describe, and evaluate current
research practices on the selection, administration, inter-
pretation, and reporting of unidimensional chronic pain
assessments in paediatric research. The unidimensional pain
assessments most commonly used with children and adoles-
cents were reviewed to explore the extent to which differences
in research practice exist. From our findings, we develop
recommendations for the future use and reporting of chronic
pain assessments with children and adolescents.
2. Methods
The systematic review is reported according to preferred
reporting items for systematic reviews and meta-analyses
[19].
2.1. Data Sources. Databases searched included Medline
(1946–28 December 2015), CINAHL (1937–18 January 2016),
Embase (1974–18 January 2016), and PsycInfo (1966–18 Jan-
uary 2016). The date of the last search attempt was 18
January 2016. In addition to database searching, articles were
identified throughother sources (reference lists of articles and
direct contact with authors when articles were irretrievable
from databases). Search terms used for the current study
included MeSH headings and keywords associated with
the following terms: “chronic pain”, “child”, “adolescen∗”,
“pain scale” (as well as specific names of pain measures
such as “visual analogue scale∗”) and “classification” (see
Appendix for full search strategy). After these search terms
were entered, articles were restricted to English language
only. Reference sections of the included studies and review
articleswere screened for further eligible papers and retrieved
where appropriate. One author (RL) conducted the system-
atic literature search and preliminary screening of article
titles/abstracts and identified full-text papers of potential
relevance. Two authors (RL and AR) independently reviewed
full-text articles for inclusion/exclusion.
2.2. Inclusion/Exclusion Criteria. Articles were included if
they were studies reporting on the use of a unidimensional
pain assessment in children and adolescents experiencing a
chronic pain condition (including diagnoses of more specific
chronic illness conditions inwhich pain is a recurring feature,
e.g., cancer, headache, and juvenile arthritis), providing that
at least one of the primary or secondary outcomes was to
assess pain intensity. Studies were included if the children and
adolescents in the study sample were between 5 and 18 years
of age, similarly to other recent systematic reviews of pain
measures used with children and adolescents [20, 21]. Only
published peer-reviewed English language, quantitative stud-
ies were considered for inclusion. Reviews, commentaries,
published abstracts, and qualitative articles were excluded.
Studies were excluded if participants who did not have a
chronic pain condition formed part of the sample. The pur-
pose of the current reviewwas to explore how pain is assessed
in children with existing chronic pain conditions, not how
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Table 1: Quality criteria and specifications.
Requirements to satisfy this criterion: satisfied if
Quality of measure selection
(i) Is the tool age appropriate?
(i) VAS used for children 7 and above
(ii) NRS used for children 8 and above
(iii) FPS used for children 4 and above
(ii) Were children screened for developmental delay or
was a measure of competency conducted prior to pain
assessment?
(i) Studies commented upon completing an assessment for
delay prior to conducting the study
(ii) They excluded children with developmental delay
(assumed they had assessed for this in order to do so)
Quality of measure administration
(i) Did the child have a chance to become familiar with
the pain scale used, for example, by rating hypothetical
scenarios?
(i) Authors commented upon conducting an assessment of
pain prior to the assessment used in the final analysis
(ii) Authors explicitly commented upon children and
adolescents having time to practice or become familiar with
the assessment
(ii) Did authors identify whether pain measurement
captured provoked pain levels or pain levels at rest?
(i) Authors specify the nature of the pain measurement
captured; for example, do authors comment upon whether
pain assessment encompasses pain levels in provoked
situations (activity) or unprovoked ones (at rest)?
(iii) Was the child the main reporter of pain at
assessment?
(i) Authors explicitly stated that children completed the scale
or questionnaire independently
(ii) Pain information was gathered as part of a clinical
interview with the child or adolescent
(iv) Were successive pain ratings observed? (i) Authors described taking more than one assessment ofpain
(v) Were consistent verbal anchors used across patients
in the same study? (i) Authors described the anchors used
Quality of measure interpretation
(i) Was a narrative explanation of pain scores also
obtained, at least at the first data collection point?
(i) Authors explicitly stated that a narrative was gained as
part of the pain assessment
(ii) Pain assessment was conducted as part of a clinical
interview
Quality of measure reporting
(i) Was the temporal frame for pain ratings reported? (i) Authors state the time scale used to frame painassessments
(ii) Were the authors clear about which type of pain was
measured?
(i) Authors describe the type of pain reported, for example,
worst, least, and most pain
pain assessment tools might be used to screen and identify
chronic pain diagnoses (e.g., in community-based epidemi-
ological studies). Where data on children with chronic pain
were reported separately, then studies were included.
The unidimensional pain assessments evaluated in the
current review include VASs, NRSs, and FPSs as these are
the most commonly used with children [22, 23]. VASs are
generally considered appropriate for use with children above
7 [24], NRSs for children aged 8 and over [25], and FPSs
for children above 4 [26]. Single-item scales used as part of
larger multidimensional pain assessments were included and
reviewed separately where details were available. However,
studies using composite measures were excluded if informa-
tion on the administration and interpretation of each of the
single-item unidimensional scales used within these was not
available separately.
2.3. Quality Criteria for Pain Scale Selection, Administration,
Interpretation, and Reporting. The quality criteria used to
assess the selected papers were created by modifying two
sets of published recommendations. The first set addressed
the issues of selection, administration, and interpretation of
pain scales with children and adolescents [8] and the second
set addressed clinical practice, education, and research [6].
These sources were chosen as the basis for the development
of quality criteria because they were specific to the use of
pain assessment tools with children and were not confined
to any particular scale or type of pain. A series of three
consensus meetings were held by three of the authors prior
to the independent critical appraisal of studies to discuss
which of these practical points and recommendations would
be appropriate to adapt to review the studies included.
Authors also discussed the importance of adding quality
criteria about the reporting of pain assessments with this
group. The more detailed specifications which would need
to be met for each criterion to be satisfied were developed,
expanded, and agreed on during these meetings (see Table 1
for criteria used and specifications for satisfying the criteria.
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153 articles sourced through Medline
259 articles sourced through CINAHL
263 articles sourced through Embase
43 articles sourced through PsycInfo
628 articles sourced through database
searching 
526 articles excluded after review of 
title/abstract (did not fulfil 
inclusion/exclusion criteria)
102 full-text articles reviewed 
16 full-text articles from other sources 
screened 
118 full-text to review in total
72 full-text articles excluded (see Table
2 for reasons for exclusion)
90 duplicates removed
46 articles included in the current review
49 scales reviewed
Identification of articles 
Screening
Included in the review
Figure 1: PRISMA flow diagram of study selection process.
Criteria which were excluded with corresponding justifica-
tion are provided in Supplementary Table 1 available online
at https://doi.org/10.1155/2017/7603758).
2.4. Data Extraction. All the included studies were crit-
ically appraised independently by two reviewers against
the ten modified quality criteria. In addition to evaluation
against quality criteria, a descriptive summary of each of
the studies was produced using a systematic approach to
data extraction.The summary provided information on each
of the following: age range of children included; adminis-
trator of the pain assessment; the person completing the
pain assessment; anchor points; numbers of successive pain
ratings; time/referent period used in the assessment; and
classification of pain level produced by the assessment.
3. Results
3.1. Description of Studies. The search returned a total of
628 articles for review (after excluding 90 duplicates) and
another 16 articles were identified through other sources (see
Figure 1). Based on titles and abstracts alone, 526 articles were
excluded. For articles of relevance, full-text versions were
located and reviewed further. Full-text review of 118 studies
resulted in 72 articles being excluded by both reviewers (see
Table 2 for justifications). Forty-six papers were included in
the final analysis (see Figure 1). Three papers commented on
the use of more than one scale [27–29]; hence a total of 49
scales were reviewed. Results reported below are described in
relation to either the total number of reported studies (46) or
the total number of different scales administered (49).
Table 2: Reasons for exclusion of studies after full-text review of
eligibility.
Reason Number of studies
Not in the defined age bracket (or does not
describe age of children/adolescents) 30
Not chronic pain 21
No measure of pain 6
Review or prevalence study 9
Pain assessment tool not described 3
Qualitative study 1
Duplicate 2
3.2. Excluded Articles. Thirty articles were excluded because
they included some study participants who were outside
of the specified age range of 5–18. For these studies, it
was not possible to identify individual data as it was not
reported separately by age. Some of these studies were also
excluded because the age range of participants included in the
study was not stated, despite the use of the terms “children”
or “adolescent” pain assessment in the study title and/or
abstract. On closer inspection, the samples included in some
of these studies were possibly misclassified as either children
or adolescents with some articles including young children
aged 3 years and under [30, 31] and young adults up to 22
years old [32].
3.3. Quality Criteria. Ten quality criteria were used to evalu-
ate the selection, administration, interpretation, and report-
ing of pain scales meaning each study review resulted in a
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(10) Pain type specified?
(9) Temporal aspect given?
(8) Narrative obtained?
(7) Consistent verbal anchors?
(6) Successive ratings?
(5) Main reporter-child?
(4) Pain identified as provoked or unprovoked?
(3) Familiarisation with scale?
(2) Developmental screening?
(1) Validated for age range?
Figure 2: Quality scores against criteria.
score of between zero and ten. Two reviewers (RL and AR)
read and evaluated the selected studies independently against
the quality criteria. On first reading, reviewers achieved
consensus on 19 (38.8%). At this point, it was recognised that
themain area of disagreement was different interpretations of
criterion 2. This was then reassessed and agreement reached
on a further 26 studies increasing agreement to over 90%. A
third author (LC) independently reviewed the four remaining
studies (LC) [15, 17, 33, 34] (see Figure 2).
Themaximum score using the quality criteria achieved by
the reviewed studies was seven out of a possible ten (median
score: 5; IQR: 4–6; see Table 3). The criteria against which
most studies scored poorly were conducting developmental
screening (19 out of 49 scales), familiarising children with the
pain scale (0 out of 49 scales), identification of the nature of
the pain measurement taken (provoked or unprovoked) (0
out of 49 scales), conduct of successive ratings of chronic pain
(17 out of 49 scales), and gaining a narrative account whilst
administering pain assessments (7 out of 49 scales).
3.4. Types of Scales. Of the 49 scales, 24 used a VAS, 19 used
a NRS, and six used a FPS (3 original, 3 revised versions) (see
Tables 4, 5, and 6 for details of administration, interpretation,
and reporting information provided in articles).
3.5. Administrators of Pain Scales. This section reports the
findings from the analysis of 49 scales as reported in 46
studies. Twenty-six of the 40 reports on scales explicitly
reported that children and/or adolescents completed the scale
themselves [27, 29, 35, 40–43, 48–52, 54, 55, 57–59, 61, 65, 66,
70–72]. Data include that from two in which more than one
scale was used [27, 29]. Eleven studies from the included 46
(23.91%) stated that pain measurements were completed with
a healthcare professional: seven with psychologists [34, 53,
56, 63, 64, 68, 69], one with a paediatric rheumatologist [54],
one with an anaesthesiologist [15], one with a paediatrician
or physiotherapist [33], and one not stating which healthcare
professional [67].
In ten studies (21.74%) parents completed pain measures
in addition to their child’s report [29, 35, 40, 42, 48, 54, 55,
58, 59, 72]. These studies reported on the use of nine scales
(one study reported the use of more than one scale used with
parents andCYP [29]). In two of the included studies (5.71%),
only parents reported pain (without an accompanying child
report) [39, 44]. In eleven of the included studies (reporting
the use of a total of 12 scales) the administrators and
completers of assessment were not described at all or reports
were ambiguous (23.91%) [17, 28, 36–38, 45–47, 60, 62, 73].
3.6. Scale Anchors. Thirty-five studies (76.09%) labelled the
“0” anchor as “No Pain” [15, 27, 28, 34, 38–44, 46, 47, 49–54,
56–65, 68, 70]. Three authors described the use of more than
one lowest anchor for scales with some using “not hurting,”
“no hurt at all,” or “no discomfort” [42, 50, 55]. Other lowest
anchors used included “I have no pain” [35] and “none” [45].
Seven studies did not report what “0” signified on the scales
used [17, 28, 29, 36, 37, 48, 71]. Eight studies (17.39%) covering
nine uses of scales did not report on the highest upper verbal
anchor used as an anchor [17, 28, 29, 33, 36, 37, 48, 71]. One
of these studies reported two different scale uses [29]. In the
remaining articles which did describe highest anchor points,
there were 16 variations in wording, namely, “Worst pain”
[45, 60, 62, 72], “Worst pain possible” [38, 40, 47, 52, 70],
“Very severe pain” [39, 46], “Worst pain imaginable” [27, 28,
41, 43, 44, 49, 53, 57, 66], “Unbearable pain” [27], “A lot of
pain” [34], “Most pain possible” [56, 63, 64, 67–69], “Worst
pain experienced” [58, 59], “Maximal pain” [61], “Worst pain
ever” [65, 73], “I have very severe pain” [35], “Hurting awhole
lot” [42, 50, 54, 55], “Severe pain” [42, 50, 54, 55], “Very
uncomfortable” [50, 55], “Very much pain” [51], and “The
strongest or worst pain you can imagine” [15].
The FPS [75] and the FPS-R [26] have standardised
instructions for highest anchor points. For the original FPS,
it is recommended that there should not be any written
or verbal anchors given to children other than the faces
themselves. Two studies in the review discussed the use of
top interpretative anchors for children who indicated pain
using the highest pain face: “worst pain” [72] and “worst pain
ever” [73]. These top anchors were implemented despite no
guidance on the interpretation of meaning of pain faces in
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standardised instructions for this scale. None of the studies
which used the FPS-R described the use of written or verbal
top anchors although it is suggested by the scale’s authors that
the top anchor should be verbally described to children as
“very much pain.”
3.7. Number of Records Kept. Two studies (4.35%) omitted
information on the number of successive pain measurements
completed [36, 48]. Of the studies that did report this, only 13
studies (28.26%) completed successive ratings of pain [27, 29,
37, 42–44, 46, 50–52, 60–62]. These 13 studies included the
use of 15 scales as two studies included the use of two scales
[27, 29]. Thirty-two studies (69.57%) explicitly reported
taking only one measurement of pain [15, 17, 27, 28, 33–
36, 38–41, 45, 47, 49, 53–59, 63–68, 70–73]. These 26 studies
reported on the use of 27 scales, with one article reporting
only onemeasurement of pain takenwithmore than one pain
scale [28]. One author described taking successive ratings of
pain with a VAS scale but only a one-off assessment with an
NRS [27].
3.8. Reference Time Frame Captured by Assessments. There
were extremely wide variations in the time periods for which
participants were due to report on pain. Three studies did
not provide details on the reference time given to frame the
assessment period [10, 39, 60]. In the remaining 43 studies
that did, over 32 different variations were used. Some gave
a specific time frame such as “Current pain” [36, 56, 67],
“Present pain” [35], “Pain over the past month” [41], “Pain at
that moment” [43, 44], “Today” [57], “Daily pain intensity”
[50], “Howmuch pain you have right now” [52], “Intensity of
pain over the past two weeks” [58], “Pain over the prior two
weeks” [62], and “Over the previous four weeks” [72, 73].
Other time frames depended on recollection of specific
pain (i.e., worst pain)without a specified time frame: “Average
pain” [46, 68], “Usual pain” [71] “Average or usual pain” [65],
“Highest, lowest, average pain” [28], “Average, worst, lowest
pain” [66], “Most, usual and least pain” [27, 48], “Current
pain level and highest pain in the days preceding” [47],
“Current, least, average and worst pain intensity” [51], and
“Current, lowest and highest pain ratings” [15, 63].
Only 35% (17) of the scales reviewed specified both time
frames and specific pain recall: “Typical pain over the past
week” [38], “Current pain at rest” [64], “Average daily pain”
[69], “Average pain intensity over the previousweek” [40, 70],
“Most severe and persistent pain” [34], “Mean intensity in the
past seven days” [29, 61], “Average of the last seven days” [29],
“Best, worst and usual pain” [59], “Maximal pain during the
past four weeks” [17], “Present and worst pain intensity for
the previous week” [42], “Current, worst and least pain in the
last 12 hours” [45], “Present pain and worst pain intensity for
the previousweek” [54, 55], and “Maximum intensity over the
last month” [28, 33].
3.9. Classification Details Given in Studies. Only two studies
(4.35%) provided information about the classification sys-
tems used to categorise pain into mild, moderate, and severe
pain categories [17, 61].This means that 95.65% of articles (44
studies) failed to describe pain classification methods. The
two studies which provided information were NRS studies
from the same research team [17, 61].
4. Discussion
Despite recent attempts to standardise assessment of chronic
pain in children and adolescents, little advice exists about
how to use and interpret pain measures within paediatric
research. Other authors have highlighted how pain is poorly
operationalised and approaches to its assessment are inade-
quately reported across research studies [2, 15, 16, 74] but, to
date, there has been no attempt to synthesise evidence from
existing pain research studies about how far this problem
extends.We conducted a systematic literature review in order
to identify, describe, and evaluate paediatric pain assessment
research practices with regard to the selection, adminis-
tration, interpretation, and reporting of chronic pain. The
review demonstrates marked variation in the administration
of paediatric pain assessments including the administrator
and completer of assessments, the anchor points, number of
records collected, time/referent periods used to frame assess-
ments, and reported systems for scoring and classification of
pain into mild, moderate, and severe pain categories.
Our review identified 46 usable studies which covered
49 reports on the use of unidimensional pain intensity
assessments in children and adolescents with chronic pain or
conditions in which chronic pain was a feature. Studies were
evaluated using a new set of quality criteria devised by the
authors which took account of von Baeyer’s [6, 8] practical
advice on the selection, administration, and interpretation
of pain scales and recommendations for clinical practice,
education, and research. None of the studies met all ten
of the quality criteria. The highest number of criteria met
was seven out of ten achieved by only three studies. This
highlights the fact that there are currently no guidelines
for reporting research use of pain scales with children and
adolescents with chronic pain. Importantly, this limits our
ability to compare pain outcomes in this patient population.
None of the researchers provided evidence that the children
were sufficiently familiar with the scale process prior to
assessment. Nor did they make it clear whether the children
were reporting levels of pain when at rest or when provoked
by activity. Studies were marginally better but still poor
at recording whether they had conducted developmental
screening or collected successive ratings of pain.
In the field of adult pain assessment in analgesic trials,
Smith and colleagues found that pain data collection was
far from standardised. They concluded that differences in
pain assessment methods influenced the inferences drawn in
the studies they reviewed [74]. In line with this and other
recent commentaries about adult pain assessment [2, 15,
16], the overall picture formed from our analysis is one of
tremendous variation in the ways in which researchers assess
pain with young individuals with chronic pain. There was no
consensus on any aspect of pain assessment administration
and interpretation. This review highlights additional issues
relating to the administration of pain scales. A significant pro-
portion of studies did not clearly describe either the person
administering the assessment or the person completing it. It
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was difficult to ascertain the degree to which parents were
involved in pain reporting in the assessed studies. Around
a quarter of all assessments were completed by a parent but
still badged as “self-report.” A similar proportion of studies
indicated that healthcare professionals were directly involved
in the administration of pain assessments to children. Little
is currently known about the effect on pain measurement
of the presence of a healthcare professional. In most of the
studies, pain scales were given to children for independent
completion without reference to the degree of cognitive
demand involved or to whether it corresponded with the
current cognitive capacity of the child [10].
The wide variation in the anchor points used to frame
pain assessment is a further source of inconsistency between
studies. Even where standardised guidance is available
regarding top anchors [75], these recommendations were not
always followed [72, 73]. Anchor points can influence pain
ratings and currently the potential influence of upper anchors
in particular is in need of further study [22]. There was
little consensus with some studies using the upper boundary
“worst imaginable” pain, whereas others used “worst pain
experienced.” A recent editorial advises caution in using
worst imaginable pain as an anchor because of the inher-
ent ambiguity for individuals when imagining the “worst
possible” pain [76]. Furthermore, the limits of “imagined”
pain may be very different depending upon previous pain
experiences leading to artificially low pain scores.
Another concern rising from the findings of the current
review was the number of studies which based conclusions
about children and adolescents with chronic pain upon one-
off assessments of the pain episode. Given that this review
was based on studies of children with chronic pain (lasting
three or more months [1]) and captures pain for children
with conditions such as juvenile idiopathic arthritis (which
is characterised by intermittent and fluctuating pain episodes
[50]), it was a surprise that so many studies limited pain
measurement to such a small fragment of the chronic pain
experience [8].
A further issue related to timing aspects of pain assess-
ment was that the studies applied widely differing time
referent points in their scales.This included different timings
on scales of the same type such as VAS or NRS scales.
This aspect of pain measure administration highlighted the
biggest discrepancy between pain researchers and there was
no evidence to support that any one of the referent points was
more widely accepted over others. There has been very little
exploration of the impact of different time reference points
[77] and what the cognitive challenges may be in asking a
child or young person to summarize a month’s worth of pain
experiences into a single response.The complexities involved
increase when we take into account the developmental
cognitive changes that occur between the ages of five and
eighteen years.
In the reviewed studies, pain classification information
was rarely presented. Almost all studies failed to report
how pain was classified and categorised or what scores were
defined as mild, moderate, and severe pain. Many of the
studies referred to mild, moderate, and severe pain cate-
gories without describing the cut points used to define each
category. This has significant implications for consistency
and comparability between studies. Scores reported by some
authors as indicatingmoderate pain actually constitutedmild
or severe pain in others. Overall, results indicate confusion
about pain scoring systems [78] which may be in part due to
the lack of information reported.
By attempting to collate specificmethodological informa-
tion from studies reporting paediatric pain assessments, the
degree of poor or incomplete reporting of the use of pain
scales became clear. The majority of studies failed to report
basic aspects of measurement procedures and interpretation
of pain scores. It was therefore difficult to ascertain whether
the use of pain assessments with this population was poor,
whether it was good but poorly reported, or both.This review
evaluated a wide range of study types from observational to
clinical trials and therefore somedifferences in administrative
methods would be expected. However, the extent to which
differences occurred within studies of the same nature is
problematic. Justifications for differences in selection, admin-
istration, or interpretation of pain scales in studies of the
same type were not provided. Most importantly, the current
situationmakes comparisons across pain studies in paediatric
research virtually impossible [2, 74].
5. Future Directions
Transparent reporting of the use of pain assessments should
lead to improvements in the interpretation, reliability, repli-
cability, and comparability of research findings [74]. As a
starting point for improving pain assessment administration
and reporting in children and adolescents with chronic
pain, we suggest that the quality criteria developed for this
systematic review are used as guidelines for the reporting
of pain assessment tools. These guidelines cover three broad
areas: (1) measurement selection, (2) measurement adminis-
tration, and (3) measurement interpretation. In addition to
the modified quality criteria, presentation and interpretation
of pain classification information should be provided.
At this stage, there is limited research evidence to suggest
that any particular administrative or interpretative methods
are better than others. However, we argue that, at the
very least by using these criteria and reporting guidelines,
researchers will be able to examine and report the differential
impacts of methods of pain scale selection, administration,
and interpretation. This will enable pain researchers to
identify and justify optimal approaches to pain assessment
to address their specified research aims. The standardisation
of pain assessment methods has been identified as a research
priority for reducing bias in pain reports [16, 17]. Standardis-
ation of assessment refers to howmeasures are used as well as
which ones are selected. Our guidelines for the reporting of
pain assessments with children and adolescents with chronic
pain will go some way towards achieving this aim.
6. Conclusions
This systematic review found that the selection, administra-
tion, interpretation, and reporting of chronic pain assess-
ments with children and adolescents are inconsistent and
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poor, and the approaches used are rarely justified.The results
of this review provide evidence to suggest that, in paediatric
pain assessment, researchers gather information through
distinctively different approaches meaning that it is hard to
compare and interpret data from different studies. This also
demonstrates that there is a weak evidence base on which to
base administrative and interpretative decisions about new
developing tools. The implications of the findings from this
review include the adoption of guidelines for reporting the
use of pain assessments with children and adolescents with
chronic pain.
Appendix
Full Search Strategy Used in Review
(1) Child∗
(2) P∗ediatric
(3) Adolescen∗
(4) Juvenile
(5) 1 or 2 or 3 or 4
(6) Pain assess∗
(7) Pain measure∗
(8) Pain scale
(9) Visual analogue scale
(10) Faces pain scale
(11) Numerical rating scale
(12) Verbal rating scale
(13) VAS
(14) NRS
(15) VRS
(16) 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15
(17) Chronic pain
(18) Musculoskeletal pain
(19) Recurrent pain
(20) 17 or 18 or 19
(21) Scor∗
(22) Classification
(23) Mild
(24) Moderate
(25) Severe
(26) Anchor∗
(27) 21 or 22 or 23 or 24 or 25 or 26
(28) 5 AND 16 AND 20 AND 27
(29) Limit to article (for Embase or journal article in
Medline)
(30) Limit to English
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